Penumbra(PEN) - 2024 Q2 - Quarterly Results
Penumbra(PEN)2024-07-30 20:15Exhibit 99.1 ALAMEDA, Calif., July 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended June 30, 2024. • U.S. thrombectomy revenue of $153.7 million in the second quarter of 2024 increased 24.9% compared to the second quarter of 2023. • Adjusted EBITDA of $46.3 million or adjusted EBITDA margin of 15.5% in the second quarter of 2024. 1 Second Quarter 2024 Financial Results Gross profit ...